Migraine with and without aura and risk for cardiovascular disease.

Current Atherosclerosis Reports
Bert B VargasBart M Demaerschalk

Abstract

Migraine, cardiovascular disease, and stroke are three highly prevalent and disabling conditions that exert a significant socioeconomic impact. The association between migraine and a twofold risk of stroke and myocardial infarction has been the topic of much debate. The mechanism underlying this link is largely unknown but may be the result of an increased prevalence of other conditions such as vasculopathies, hypercoagulable states, and patent foramen ovale seen in migraine with aura. Although many prior studies have demonstrated increased risks in women with migraine with aura, an emerging body of evidence is showing similar risks in men. These risks are further compounded with increased migraine frequency, smoking, and the use of oral contraceptive pills. Because the overall risk for stroke and myocardial infarction in migraineurs remains relatively low, recommendations at this time are limited to the modification of cardiovascular risk factors, such as smoking cessation and the avoidance of oral contraceptive pills, especially in women suffering from migraine with aura.

References

Jun 25, 1992·Annals of Internal Medicine·S T O'KeeffeW P Beetham
Aug 1, 1990·Cephalalgia : an International Journal of Headache·K KovácsE Csanda
Nov 12, 1983·British Medical Journal·W E WatersP C Elwood
Jul 27, 2001·Neurology·G E TietjenS A Khuder
Dec 6, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·UNKNOWN ACOG Committee on Practice Bulletins-Gynecology
Feb 14, 2003·The New England Journal of Medicine·Jonathan M HillToren Finkel
May 20, 2004·Headache·David W DodickStephen Silberstein
May 20, 2004·Headache·Vasilios Papademetriou
Aug 18, 2004·Archives of Neurology·Katayoun VahediMarie-Germaine Bousser
Jul 22, 2005·Cephalalgia : an International Journal of Headache·A PezziniC Zanferrari
Dec 21, 2005·Annals of Neurology·Ann I ScherLenore J Launer
Jul 20, 2006·JAMA : the Journal of the American Medical Association·Tobias KurthJulie E Buring
Aug 18, 2006·Neurology·D L BrownL B Morgenstern
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 31, 2007·Neurology·R B LiptonUNKNOWN AMPP Advisory Group
Mar 10, 2007·Cephalalgia : an International Journal of Headache·G LiewP Mitchell
Apr 25, 2007·Archives of Internal Medicine·Tobias KurthJulie E Buring
Apr 27, 2007·Neurology·Floris H VanmolkotJan N de Hoon
May 15, 2007·Current Opinion in Neurology·Hans-Christoph DienerDavid Dodick
Jul 31, 2007·Cephalalgia : an International Journal of Headache·E Gretchen Tietjen
Aug 11, 2007·Stroke; a Journal of Cerebral Circulation·Leah R MacClellanSteven J Kittner
Sep 1, 2007·Stroke; a Journal of Cerebral Circulation·Tomás SobrinoJosé Castillo
Nov 8, 2007·Cephalalgia : an International Journal of Headache·T KurthJ E Buring
Dec 7, 2007·Headache·Claudia BeckerChristoph R Meier
Mar 22, 2008·Cephalalgia : an International Journal of Headache·T J SchwedtD W Dodick

❮ Previous
Next ❯

Citations

May 27, 2014·The International Journal of Cardiovascular Imaging·Ezgi KalaycıoğluSükrü Celik
Nov 18, 2010·Women's Health·Nilson Roberto de Melo
May 17, 2011·Cephalalgia : an International Journal of Headache·Bart M Demaerschalk
Jun 6, 2009·Stroke; a Journal of Cerebral Circulation·José R RomeroViken L Babikian
Dec 2, 2020·Clinical Neurology and Neurosurgery·Gulnur Tekgol UzunerNevzat Uzuner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.